Professur für Molekulare Mechanismen der Organfibrose

Reallocation / Closing: 30.09.2022


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis (2015) Ochoa E, Martin JE, Assassi S, Beretta L, Carreira P, Guillen A, Simeon CP, et al. Journal article Cardiomyopathy in murine models of systemic sclerosis (2015) Venalis P, Kumanovics G, Schulze-Koops H, Distler A, Dees C, Zerr P, Palumbo-Zerr K, et al. Journal article From pathogenesis to therapy - Perspective on treatment strategies in fibrotic diseases (2015) Dees C, Distler J, Ramming A Journal article Orphan nuclear receptor NR4A1 regulates transforming growth factor-? signaling and fibrosis (2015) Palumbo-Zerr K, Zerr P, Distler A, Fliehr J, Mancuso R, Huang J, Mielenz D, et al. Journal article Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages (2015) Beyer C, Huang J, Beer J, Zhang Y, Palumbo-Zerr K, Zerr P, Distler A, et al. Journal article Common German language nomenclature for systemic sclerosis (2015) Aringer M, Mueller-Ladner U, Burkhardt H, Distler J, Distler O, Graninger WB, Guenther C, et al. Journal article The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis (2014) Avouac J, Palumbo-Zerr K, Ruzehaji N, Tomcik M, Zerr P, Dees C, Distler A, et al. Journal article SIGNATURE OF CIRCULATING MICRORNAS IN OSTEOARTHRITIS (2014) Beyer C, Zampetaki A, Lin NY, Kleyer A, Perricone C, Iagnocco AM, Distler A, et al. Conference contribution Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability (2014) Distler A, Lang V, Del Vecchio T, Huang J, Zhang Y, Beyer C, Lin NY, et al. Journal article Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis (2014) Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler J, Fierlbeck G, Genth E, et al. Journal article